Status:
COMPLETED
Active Screening of Latent TB Infection, Treatment and Long Term Follow-up in Prison
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Tuberculosis
Eligibility:
MALE
Phase:
PHASE3
Brief Summary
LTBI Treatment is effective in prison
Detailed Description
LTBI treatment will be conducted in a prison with either isoniazid or rifampin
Eligibility Criteria
Inclusion
- all people who is LTBI, and have ability to sign the informed concent
Exclusion
- previously adverse effect from anti-TB medication complete treatment of TB in the pass; active TB AST, ALT \> 3 times of normal limit platelet \< 150 k/mm3 T-bil \> 2 times of normal limit
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2010
Estimated Enrollment :
2384 Patients enrolled
Trial Details
Trial ID
NCT00767975
Start Date
January 1 2008
End Date
November 1 2010
Last Update
November 29 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taipei Prison
Taoyuan District, Taiwan